What is supported
Randomised evidence exists for structured electronic symptom monitoring in oncology. Those findings depend on the questionnaires, frequency, populations and clinical-response pathways used.
What remains earlier-stage
Wearable studies are numerous, but many assess technical or user feasibility and correlations rather than clinical outcome change. This is not the same level of evidence as a validated care intervention.
Editorial standard
- Primary studies, registries and regulator sources first.
- Results, limitations and applicability stated separately.
- Visible review date and open citations.
- Correction when evidence or product status changes.